Research Update Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Research update study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Research Update Study Today - Breaking & Trending Today

EQS-News: New Formula Leverages Proenkephalin A 119-159 (penKid) for Improved GFR Estimation in Steady-State and Critically Ill Patients

Issuer: SphingoTec GmbH / Key word(s): Research Update/Study results New Formula Leverages Proenkephalin A 119-159 (penKid) for Improved GFR Estimation in Steady-State and Critically Ill Patients 05.10.2023 / 10:00 CET/CEST The issuer is solely responsible for the content of this announcement. P. ....

United States , Sphingotec Gmbh , Ruxandra Lenz , Florian Uhle , Sphingotec Gmb , Pickkerset Al , Research Update Study , Radboud University , Disease Quality Initiative , Distribution Services , Peter Pickkers Head Of Research , Radboud University Medical Centre , Kidney International , Formula Leverages Proenkephalin , Critically Ill Patients , Mayo Clinic , Peter Pickkers , Intensive Care Medicine , Radboud University Nijmegen Medical Centre , Medical Director , Kidney International Reports , Acute Disease Quality Initiative , Nature Reviews Nephrology , Intensive Care Med Exp , Tec Gmbh , Corporate News ,

EQS-News: SphingoTec GmbH: New Formula Leverages Proenkephalin A 119-159 (penKid) for Improved GFR Estimation in Steady-State and Critically Ill Patients

EQS-News: SphingoTec GmbH: New Formula Leverages Proenkephalin A 119-159 (penKid) for Improved GFR Estimation in Steady-State and Critically Ill Patients
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , Sphingotec Gmb , Florian Uhle , Ruxandra Lenz , Pickkerset Al , Sphingotec Gmbh , Peter Pickkers Head Of Research , Disease Quality Initiative , Radboud University , Radboud University Medical Centre , Research Update Study , Kidney International , Distribution Services , Formula Leverages Proenkephalin , Critically Ill Patients , Mayo Clinic , Peter Pickkers , Intensive Care Medicine , Radboud University Nijmegen Medical Centre , Medical Director , Kidney International Reports , Acute Disease Quality Initiative , Nature Reviews Nephrology , Intensive Care Med Exp , Tec Gmbh , Corporate News ,

EQS-News: ADQI Group Recognizes PenKid as Relevant Functional Biomarker for Sepsis-Associated Acute Kidney Injury

Issuer: SphingoTec GmbH / Key word(s): Research Update/Study results ADQI Group Recognizes PenKid as Relevant Functional Biomarker for Sepsis-Associated Acute Kidney Injury 04.04.2023 / 10:00 CET/CEST The issuer is solely responsible for the content of this announcement. The Acute Disease Qualit. ....

Sphingotec Gmb , Sphingotec Gmbh , Ruxandra Lenz , Florian Uhle , Distribution Services , Group Recognizes Penkid As Relevant Functional Biomarker , Disease Quality Initiative , Research Update Study , Recognizes Penkid , Relevant Functional Biomarker , Sepsis Associated Acute Kidney Injury , Acute Disease Quality Initiative , Medical Director , Rev Nephrol , Tec Gmbh , Corporate News , Regulatory Announcements , Epsis Associated , Et Cest ,

EQS-News: SphingoTec GmbH: ADQI Group Recognizes PenKid as Relevant Functional Biomarker for Sepsis-Associated Acute Kidney Injury

Issuer: SphingoTec GmbH / Key word(s): Research Update/Study results ADQI Group Recognizes PenKid as Relevant Functional Biomarker for Sepsis-Associated Acute Kidney Injury 04.04.2023 ....

Florian Uhle , Sphingotec Gmb , Sphingotec Gmbh , Ruxandra Lenz , Research Update Study , Distribution Services , Group Recognizes Penkid As Relevant Functional Biomarker , Disease Quality Initiative , Recognizes Penkid , Relevant Functional Biomarker , Sepsis Associated Acute Kidney Injury , Acute Disease Quality Initiative , Medical Director , Rev Nephrol , Tec Gmbh , Corporate News , Regulatory Announcements ,

Kinarus Therapeutics Phase 2 KINFAST Covid-19 Clinical Trial Progress Update

Kinarus Therapeutics Holding AG / Key word(s): Research Update/Study Kinarus Therapeutics Phase 2 KINFAST Covid-19 Clinical Trial Progress Update 21.02.2023 / 07:00 CET/CEST MEDIA RELEASE KINFAST is evaluating KIN001 for reduction in severity and duration of Covid-19 symptoms KINFAST is actively. ....

Chris Maggos , Thierry Fumeaux , Research Update Study , Kinarus Therapeutics Holding Ag Key , Swiss Federal Office Of Public Health , Cohesion Bureau , Kinarus Therapeutics Holding , Programme For Covid , Therapeutics Phase , Trial Progress Update , Therapeutics Holding , Chief Medical Officer , Kinarus Therapeutics , Swiss Federal Office , Covid 19 , Et Cest ,